Gain Therapeutics Announces 2024 R&D Update on Parkinson's Disease with KOL & Analyst Insight Seite 1

14.02.2024 - Event, moderated by Hartaj Singh and Eka Gigauri of Oppenheimer & Co., will be held on Thursday, February 22, 2024 at 11:00 am ESTBETHESDA, Md., Feb. 14, 2024 (GLOBE NEWSWIRE) - Gain Therapeutics, Inc., (Nasdaq: GANX), a clinical-stage ... Seite 1

Related Keywords

Israel ,Germany ,Tel Aviv ,Matthias Alder ,Tiago Fleming Outeiro ,Joanne Taylor ,Roy Alcalay ,Professor At Newcastle University ,University Medical Center ,Department Of Experimental Neurodegeneration ,Columbia University ,Movement Disorder Society ,Symptomatic Treatment ,Gain Therapeutics Rd Update ,Executive Officer ,Senior Vice President ,Movement Disorders Division ,Tel Aviv Sourasky Medical Center ,Foundation Funded Parkinson ,Markers Initiative ,Experimental Neurodegeneration ,Task Force ,Biological Definition ,Internation Parkinson ,Movement Disorder ,Gain Therapeutics Chart ,Ain Therapeutics Kurs ,Ain Therapeutics Aktie ,